Question to the HM Treasury:

To ask the Chancellor of the Exchequer, if she will increase the funding available to British Patient Capital's Future Fund: Breakthrough.

At Autumn Budget 2024 the government announced that it will increase funding for the £425m Future Fund: Breakthrough programme to co-invest in high-growth, innovative firms.

The programme, delivered by the Bank’s commercial subsidiary, British Patient Capital, makes equity co-investments with private sector investors in growth stage R&D-intensive UK companies operating in breakthrough technology sectors.

Future Fund: Breakthrough supports the growth of the UK’s most innovative companies and will help to provide an investment pipeline to pension fund investment through the work to develop the British Growth Partnership.